A qualitative study on the adverse reactions of mass treatment for lymphatic filariasis in Orissa,India

被引:0
|
作者
Babu BV [1 ]
机构
[1] Division of Epidemiology,Regional Medical Research Centre,Indian Council of Medical Research,Bhubaneswar-751 023,India & Indian Council of Medical Research,New Delhi 110 029,India
关键词
Lymphatic filariasis; Mass drug administration; Adverse reactions; Qualitative study; Orissa; India;
D O I
暂无
中图分类号
R532.15 [丝虫病(象皮病)];
学科分类号
1002 ; 100201 ;
摘要
Objective:To describe the perceptions of community members and programme partners regarding severity,management and impact of adverse reactions on mass drug administration (MDA) compliance.Methods:Based on various qualitative data collected from five districts of Orissa,India,where MDA had been implemented during 2002 and 2004.The qualitative surveys included focus group discussions with community members and health workers,and semi-structured interviews with key informants in the community,medical officers at primary health centres,district level health officers and private practitioners.Results:It showed that many people suffered from adverse reactions,though the reactions were not serious.The paper reported different ways of management of adverse reactions at the community level.The impact of adverse reactions on MDA compliance was serious,as many people did not consume the drug due to fear of adverse reactions.The rumours of adverse reactions and news in media deterred people from consuming the tablets.Conclusion:All categories of respondents indicates the need of more information to address the problem of adverse reactions during MDA.The present paper warrants incorporating the messages on adverse reactions during health communication and social mobilization campaigns of MDA.
引用
收藏
页码:55 / 58
页数:4
相关论文
共 50 条
  • [21] Mass drug administration to eliminate lymphatic filariasis in Southern India
    Pattanshetty, Sanjay
    Kumar, Ashwini
    Kumar, Ravi
    Rao, Chythra R.
    Badiger, Sanjeev
    Rashmi, R.
    Kamath, Sneha
    AUSTRALASIAN MEDICAL JOURNAL, 2010, 3 (13): : 847 - 850
  • [22] Use of an inclusive-partnership strategy in urban areas of Orissa, India, to increase compliance in a mass drug administration for the control of lymphatic filariasis
    Babu, B. V.
    Behera, D. K.
    Kerketta, A. S.
    Mishra, S.
    Rath, K.
    Swain, B. K.
    Mishra, S.
    Kar, S. K.
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2006, 100 (07): : 621 - 630
  • [23] ADVERSE REACTIONS FOLLOWING MASS DRUG ADMINISTRATION WITH DIETHYLCARBAMAZINE AND ALBENDAZOLE FOR LYMPHATIC FILARIASIS ELIMINATION IN WEST SUMATERA, INDONESIA
    Widiastuti, Dyah
    Kesuma, Agung Puja
    Jastal
    Kusrini, Ina
    Wijayanti, Siwi Pramatama Mars
    Dhewantara, Pandji Wibawa
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2021, 52 (01) : 1 - 10
  • [24] SERUM INTERLEUKIN-6 LEVELS AND ADVERSE REACTIONS TO DIETHYLCARBAMAZINE IN LYMPHATIC FILARIASIS
    YAZDANBAKHSH, M
    DUYM, L
    AARDEN, L
    PARTONO, F
    JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02): : 453 - 454
  • [25] Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance
    Babu, Bontha V.
    Mishra, Suchismita
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2008, 102 (12) : 1207 - 1213
  • [26] Neglected Patients with a Neglected Disease? A Qualitative Study of Lymphatic Filariasis
    Perera, Myrtle
    Whitehead, Margaret
    Molyneux, David
    Weerasooriya, Mirani
    Gunatilleke, Godfrey
    PLOS NEGLECTED TROPICAL DISEASES, 2007, 1 (02):
  • [27] Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
    Hussain, Mohammad A.
    Sitha, Ashok K.
    Swain, Subhashisa
    Kadam, Shridhar
    Pati, Sanghamitra
    INFECTIOUS DISEASES OF POVERTY, 2014, 3
  • [28] Frequency and Clinical Significance of Localized Adverse Events following Mass Drug Administration for Lymphatic Filariasis in an Endemic Area in South India
    Kuttiatt, Vijesh Sreedhar
    Somani, Roopali K.
    Swaminathan, Subramanian
    Krishnamoorthy, Kaliannagounder
    Weil, Gary J.
    Purushothaman, Jambulingam
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 102 (01): : 96 - 99
  • [29] Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance
    Mohammad A Hussain
    Ashok K Sitha
    Subhashisa Swain
    Shridhar Kadam
    Sanghamitra Pati
    Infectious Diseases of Poverty, 3
  • [30] INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR IN THE PATHOGENESIS OF ADVERSE REACTIONS AFTER TREATMENT OF LYMPHATIC FILARIASIS AND ONCHOCERCIASIS
    TURNER, PF
    ROCKETT, KA
    OTTESEN, EA
    FRANCIS, H
    AWADZI, K
    CLARK, IA
    JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (05): : 1071 - 1075